Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

We Can Shorten the Journey

February 1, 2024 | Medscape Education, Patient journey, impact, outcomes, rare disease 

- PMLiVE

During the shortest month of the year, Medscape Education is making a renewed commitment to use clinician education to help shorten the diagnostic and treatment journey for the millions of people living with a rare disease.

One in 17 people will be affected by a rare disease at some point in their lives, and patients with a rare disease often experience a long journey to getting a diagnosis and appropriate treatment. This journey lasts 4 to 5 years on average and sometimes as long as 10 years, and is often fraught with misdiagnosis; ineffective, inappropriate, or damaging  treatments; and personal hardship.

For rare disease day on February 29, and throughout the month of February, Medscape Education is making a commitment to Shorten the Journey for patients everywhere through the power of education.

Follow Medscape Education on LinkedIn for more information on the expansive resources and powerful impact of Medscape rare disease education throughout the month.

For more information on rare disease education at Medscape, please contact S.Christy Rohani-Montez.

About Medscape Education

Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professionals.

This content was provided by Medscape Education

Company Details

Medscape Logo

Medscape Education

Email
Website

 Latest Content from  Medscape Education 

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Does Rare Disease Education Work?

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.

From Genetic Puzzles to Precision Therapeutics

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...

Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series

Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...

What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?

Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...

“CGM Sweet Talk With the Sugar Queens” Takes Silver at the 2025 Digital Health Awards

Medscape Education’s dynamic educational series, CGM Sweet Talk With the Sugar Queens, has earned a Silver Award in the Video Series (Digital Health Media / Publications) category at the 2025...

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...

Women Leaders Rewriting the Protocols of Rare Disease Care

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...